Characteristics of the COVID-19-Positive and COVID-19-Negative Patients in the Cohort
| Total (N = 10,646) | Severe COVID-19 (N= 114) | Mild/Moderate COVID-19 (N = 211) | No COVID-19 (N = 10,321) | P value* | |
|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | ||
| Any hospitalization | 1626 (15.3) | 34 (29.8) | 18 (8.5) | 1574 (15.3) | <.001 |
| Combined group of hospitalizations | 891 (8.4) | 27 (23.7) | 14 (6.6) | 850 (8.2) | <.001 |
| Cardiovascular hospitalizations | 637 (6.0) | 21 (18.4) | 9 (4.3) | 607 (5.9) | <.001 |
| Respiratory hospitalizations | 491 (4.6) | 17 (14.9) | 7 (3.3) | 467 (4.5) | <.001 |
| Clotting hospitalizations | 195 (1.8) | 8 (7.0) | 2 (0.9) | 185 (1.8) | <.001 |
| Male | 4329 (40.7) | 47 (41.2) | 79 (37.4) | 4203 (40.8) | .626 |
| Non-Hispanic White | 6713 (63.1) | 46 (40.4) | 96 (45.5) | 6571 (63.7) | <.001 |
| Non-Hispanic Black | 2560 (24.0) | 55 (48.2) | 61 (28.9) | 2444 (23.7) | <.001 |
| Hispanic | 640 (6.0) | 7 (6.1) | 28 (13.3) | 605 (5.9) | <.001 |
| Age, years | |||||
| 18-29 | 1309 (12.3) | 10 (8.8) | 50 (23.7) | 1249 (12.1) | <.001 |
| 30-44 | 2119 (19.9) | 13 (11.4) | 46 (21.8) | 2060 (20.0) | .059 |
| 45-64 | 3847 (36.1) | 29 (25.4) | 75 (35.5) | 3743 (36.3) | .056 |
| 65 and older | 3371 (31.7) | 62 (54.4) | 40 (19.0) | 3269 (31.7) | <.001 |
| Insurance | 10,312 (96.9) | 114 (100.0) | 194 (91.9) | 10,004 (96.9) | <.001 |
| Diabetes mellitus | 2820 (26.5) | 64 (56.1) | 45 (21.3) | 2711 (26.3) | <.001 |
| Hypertension | 5719 (53.7) | 89 (78.1) | 88 (41.7) | 5542 (53.7) | <.001 |
| COPD | 3174 (29.8) | 39 (34.2) | 36 (17.1) | 3099 (30.0) | <.001 |
| Overweight | 2714 (25.5) | 30 (26.3) | 61 (28.9) | 2623 (25.4) | .504 |
| Obese | 3813 (35.8) | 41 (36.0) | 88 (41.7) | 3684 (35.7) | .197 |
COVID-19, Coronavirus disease 2019.
↵* Results from χ2 tests.